Cite
HARVARD Citation
Eriksen, J. et al. (n.d.). OC-0271: 5-Y update of the randomized phase III trial DAHANCA19: Primary (Chemo) RT +/- zalutumumab in HNSCC. Radiotherapy and oncology. pp. S137-S138. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Eriksen, J. et al. (n.d.). OC-0271: 5-Y update of the randomized phase III trial DAHANCA19: Primary (Chemo) RT +/- zalutumumab in HNSCC. Radiotherapy and oncology. pp. S137-S138. [Online].